immunostains

the pathologist performed immunostains to determine the tumor origin.

positive immunostains for cd20 confirmed the diagnosis of b-cell lymphoma.

immunostains are routinely used to distinguish between different types of carcinoma.

the immunostains revealed strong nuclear staining for estrogen receptors.

negative immunostains for melan-a helped rule out melanoma.

we ordered immunostains to characterize the poorly differentiated neoplasm.

the immunostains demonstrated diffuse cytoplasmic positivity for cytokeratin.

results of the immunostains should be available within 48 hours.

immunostains help differentiate between inflammatory and neoplastic conditions.

the pathology report includes a panel of immunostains for accurate classification.

we interpreted the immunostains in conjunction with the morphological findings.

repeat immunostains were performed due to the equivocal initial results.